abstract |
The present invention describes an adjuvant composition comprising an antimicrobial agent, in particular an azalide, wherein the antimicrobial agent acts as an adjuvant. In particular, the adjuvant composition is a vaccine adjuvant. The invention further describes a vaccine comprising (a) at least one antigen, and (b) at least one antimicrobial agent, in particular several components comprising azalide, wherein the azalide acts as an adjuvant. The adjuvant composition or vaccine of the present invention is useful for the prevention and treatment of diseases caused by pathogenic agents, cancerous cells or allergens. |